Unique to the industry, Heidenhain has announced the launch of the new straight-cut CNC control, the TNC 128. User-friendly and very intuitive best describe this new control designed for use with milling, drilling and boring machines.
InVivo Therapeutics shares plunged some 22% today after the medical device company reported that its interim CFO, appointed 2 weeks ago after the sudden departure of CEO & CFO Frank Reynolds, had resigned effective immediately. NVIV shares were trading at $1.61 each as of about 3:20 p.m. today, down 21.5%.
Vishay Intertechnology has introduced a new series of TANTAMOUNT surface-mount solid tantalum molded chip capacitors designed to provide improved performance and reliability in a wide variety of non-life-support medical monitoring and diagnostic instruments for in-home and hospital use.
The end-of-August announcement that the National Football League will pay $765 million to settle a lawsuit involving thousands of its former players over problems related to head trauma is just one sign of the growing concern that the sport’s collisions pose a serious risk to long-term player health.
Discussion and collaboration between a medical device designer and a molding partner early in the design process can save significant expense and help avoid manufacturing obstacles that would otherwise not emerge until production has begun. This article looks at the great benefits realized from early cooperation between these two parts of the product development lifecycle.
Over 200 million people have downloaded a healthcare application to their smartphone. However, only a small number of those downloaded apps are used regularly and, since most apps are free, even a smaller number of applications actually generate any revenue.
SynCardia Systems, Inc. announced today that Matthew Green, the UK's 1st patient to be discharged with the SynCardia temporary Total Artificial Heart, has been successfully bridged to transplant after almost two years of support. Green, his wife and their 7-year-old son celebrated his new beginning with a holiday.
Chinese researchers have started 3D printing kidneys out of living cells, providing the stepping stones to 3D-printed, fully-implantable organs. So, what's keeping these things from starting a new revolution in organ transplantation?
The U.S. is facing a crisis in how to deliver cancer care, as the baby boomers reach their tumor-prone years and doctors have a hard time keeping up with complex new treatments, government advisers reported Tuesday. The caution comes even as scientists are learning more than ever about...
Tyber Medical, a privately held medical device company focused on developing innovative spine and orthopaedic devices for private label opportunities, announces CE Mark approval for TyPEEK, a proprietary titanium plasma sprayed PEEK interbody system.
New Federal Food & Drug Administration regulations have streamlined the governance of combination products — medical devices embedded with pharmaceutical or biologic components. A new white paper titled Combination Products 3.0: Applying the New FDA Regulations in 2013 discusses the implications for manufacturers.
Stockholm-based medical device company Elekta landed a $25 million contract to provide its Leksell Gamma Knife Perfexion systems to the People's Republic of China, marking the largest order to date for the Leksell system. The new contract even further cements the Chinese market as the 2nd largest for Elekta, which has a corner on about 48% of the radiation therapy market there.
Major contractors hooking up the internal plumbing of President Barack Obama's health care law projected confidence Tuesday that they will be ready to go by an Oct. 1 deadline, even though the system is still being tested. With just three weeks to go before new state health insurance markets launch, efforts are ongoing to reliably link up government agencies, the markets themselves and private health plans.
The Horw, Switzerland-based company said the round was led by a pair of new, private investors and was joined by all existing backers, including BMC Ventures A/S, Endeavour Vision SA, Schroder & Co. Bank AG and Venture Incubator AG. The PaQ device won CE Mark approval in the European Union in November 2012 for Type II diabetes.
Richard Van As, a South African carpenter, lost four fingers from his right hand to a circular saw two years ago. He was unable to afford the tens of thousands of dollars to get a myoelectric hand, which detects a muscle's electric impulses to activate an artificial limb.